Sohrab Salimi1, Hamid Reza Khayat Kashani2, Shirzad Azhari3, Sohrab Sadeghi3, Siavash Sheikhghomy3, Poorya Paryan3, Maryam KhayatKashani1. 1. Clinical Research and Development Unit, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Neurosurgery, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Madani street, Tehran, Iran. hrkhka@gmail.com. 3. Department of Neurosurgery, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Madani street, Tehran, Iran.
Abstract
PURPOSE: This prospective randomized controlled trial hypothesizes that intra wound vancomycin reduces postoperative infection. METHODS: In this RCT study, the patients were randomly divided into two groups of treatment and control. In the treatment group, 1-2 g of intra wound vancomycin was used, and no drug was used for the control group. SSI and the type of microorganism causing postoperative infection were assessed at a three-month follow-up. Factors affecting postoperative infection such as age, sex, site of operation, surgical levels, and risk factors affecting postoperative infection, such as diabetes, blood pressure, ischemic heart disease, smoking, blood transfusion, BMI, neurologic deficit, CSF leakage, UTI, COPD and surgery time were examined in two groups. RESULTS: In this study, 375 patients, including 187patients in the treatment group and 188 patients in the control group, were studied. Among the patients, 228 had surgery without instrumentation, and 147 had surgery with instrumentation. There were 12 cases of SSI in the treatment group and 11 in the control group, and there was no statistically significant difference between the two groups. There was no difference between the two groups with and without instrumentation in the evaluation of postoperative infection. In the subgroups with and without instruments, there was no significant difference between treatment and control groups. Due to the microorganism causing the infection, gram-negative bacteria were more common in the treatment group. CONCLUSION: Intra-wound vancomycin has no effect on SSI; in addition, it can increase the rate of gram-negative infections.
PURPOSE: This prospective randomized controlled trial hypothesizes that intra wound vancomycin reduces postoperative infection. METHODS: In this RCT study, the patients were randomly divided into two groups of treatment and control. In the treatment group, 1-2 g of intra wound vancomycin was used, and no drug was used for the control group. SSI and the type of microorganism causing postoperative infection were assessed at a three-month follow-up. Factors affecting postoperative infection such as age, sex, site of operation, surgical levels, and risk factors affecting postoperative infection, such as diabetes, blood pressure, ischemic heart disease, smoking, blood transfusion, BMI, neurologic deficit, CSF leakage, UTI, COPD and surgery time were examined in two groups. RESULTS: In this study, 375 patients, including 187patients in the treatment group and 188 patients in the control group, were studied. Among the patients, 228 had surgery without instrumentation, and 147 had surgery with instrumentation. There were 12 cases of SSI in the treatment group and 11 in the control group, and there was no statistically significant difference between the two groups. There was no difference between the two groups with and without instrumentation in the evaluation of postoperative infection. In the subgroups with and without instruments, there was no significant difference between treatment and control groups. Due to the microorganism causing the infection, gram-negative bacteria were more common in the treatment group. CONCLUSION: Intra-wound vancomycin has no effect on SSI; in addition, it can increase the rate of gram-negative infections.
Authors: Kaisorn L Chaichana; Mohamad Bydon; David R Santiago-Dieppa; Lee Hwang; Gregory McLoughlin; Daniel M Sciubba; Jean-Paul Wolinsky; Ali Bydon; Ziya L Gokaslan; Timothy Witham Journal: J Neurosurg Spine Date: 2013-11-08
Authors: Jonathan R Edwards; Kelly D Peterson; Yi Mu; Shailendra Banerjee; Katherine Allen-Bridson; Gloria Morrell; Margaret A Dudeck; Daniel A Pollock; Teresa C Horan Journal: Am J Infect Control Date: 2009-12 Impact factor: 2.918
Authors: George M Ghobrial; Michael Y Wang; Barth A Green; Howard B Levene; Glen Manzano; Steven Vanni; Robert M Starke; George Jimsheleishvili; Kenneth M Crandall; Marina Dididze; Allan D Levi Journal: J Neurosurg Spine Date: 2017-11-24
Authors: Nitin Agarwal; Prateek Agarwal; Ashley Querry; Anna Mazurkiewicz; Zachary J Tempel; Robert M Friedlander; Peter C Gerszten; D Kojo Hamilton; David O Okonkwo; Adam S Kanter Journal: J Neurosurg Spine Date: 2018-04-27
Authors: Paul A Anderson; Jason W Savage; Alexander R Vaccaro; Kristen Radcliff; Paul M Arnold; Brandon D Lawrence; Mohammed F Shamji Journal: Neurosurgery Date: 2017-03-01 Impact factor: 4.654
Authors: Jacques Merrer; Laetitia Desbouchages; Valérie Serazin; Jimmy Razafimamonjy; François Pauthier; Michel Leneveu Journal: Infect Control Hosp Epidemiol Date: 2006-11-21 Impact factor: 3.254
Authors: A G Tsantes; D V Papadopoulos; T Lytras; A E Tsantes; A F Mavrogenis; P Koulouvaris; I D Gelalis; A Ploumis; A V Korompilias; T Benzakour; G Tsivgoulis; S Bonovas Journal: J Hosp Infect Date: 2019-09-25 Impact factor: 3.926
Authors: Jamal N Shillingford; Joseph L Laratta; Hemant Reddy; Alex Ha; Ronald A Lehman; Lawrence G Lenke; Charla R Fischer Journal: Spine Deform Date: 2018 Nov - Dec